Hamilton, ON (Oct. 17, 2022) -- When a public health crisis happens, it’s often quickly an international problem, and health-care professionals around the world need to have rapid access to the best guidelines for diagnosis and treatment as well as policy direction.
A research team led by Holger Schünemann of McMaster University has found that a website giving a map of the recommendations works better than a conventional website for distributing the information effectively.
The study was done for the World Health Organization (WHO) and Canadian Institutes of Health Research testing accessibility to recommendations for tuberculosis, a preventable and curable disease which is still the world’s top infectious killer.
“What are public health recommendations worth, if the public doesn’t understand them,” said Schünemann, a McMaster professor of clinical epidemiology and medicine as well as co-director of the WHO Collaborating Centre for Infectious Diseases, Research Methods and Recommendations.
“We found the new approach is much more accessible, people are more satisfied and, most important, we tested and found the new presentation improved the understanding of the information.”
The WHO eTB Guidelines are found at https://who.tuberculosis.recmap.org/grid , and the paper was published by PLOS Global Public Health at https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001166 .
Schünemann added that the research group has also applied the methodology to digitize and present all COVID-19 guidelines.
-30-
Editors:
A photo of Holger Schünemann may be found at https://bit.ly/3gj4RgM
-30-.
For information, please contact:
Veronica McGuire
Media Relations
Faculty of Health Sciences
McMaster University
289-776-6952
PLOS Global Public Health
Randomized controlled/clinical trial
People
Comparing the usability of the World Health Organization’s conventional tuberculosis guidelines to the eTB recommendations map: A two-arm superiority randomised controlled trial
14-Oct-2022
Competing interests: We have read the journal’s policy and the authors of this manuscript have the following competing interests. ML grants and personal fees from the WHO Essential Medicines List (EML). TL, NS, DM, ZC, AH, TP, and BD have no conflicts of interest to disclose. HJS has received research funding and honoraria from the WHO.